1. Home
  2. BCS vs RMD Comparison

BCS vs RMD Comparison

Compare BCS & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCS
  • RMD
  • Stock Information
  • Founded
  • BCS 1690
  • RMD 1989
  • Country
  • BCS United Kingdom
  • RMD United States
  • Employees
  • BCS N/A
  • RMD N/A
  • Industry
  • BCS Commercial Banks
  • RMD Medical/Dental Instruments
  • Sector
  • BCS Finance
  • RMD Health Care
  • Exchange
  • BCS Nasdaq
  • RMD Nasdaq
  • Market Cap
  • BCS 45.4B
  • RMD 36.5B
  • IPO Year
  • BCS N/A
  • RMD 1995
  • Fundamental
  • Price
  • BCS $13.18
  • RMD $234.84
  • Analyst Decision
  • BCS
  • RMD Buy
  • Analyst Count
  • BCS 0
  • RMD 11
  • Target Price
  • BCS N/A
  • RMD $227.63
  • AVG Volume (30 Days)
  • BCS 10.2M
  • RMD 1.2M
  • Earning Date
  • BCS 10-24-2024
  • RMD 10-24-2024
  • Dividend Yield
  • BCS 3.15%
  • RMD 0.90%
  • EPS Growth
  • BCS N/A
  • RMD 22.60
  • EPS
  • BCS 0.37
  • RMD 7.54
  • Revenue
  • BCS $31,629,808,326.00
  • RMD $4,807,485,000.00
  • Revenue This Year
  • BCS N/A
  • RMD $10.09
  • Revenue Next Year
  • BCS $5.49
  • RMD $7.15
  • P/E Ratio
  • BCS $8.33
  • RMD $31.13
  • Revenue Growth
  • BCS N/A
  • RMD 9.88
  • 52 Week Low
  • BCS $7.02
  • RMD $147.39
  • 52 Week High
  • BCS $13.57
  • RMD $260.49
  • Technical
  • Relative Strength Index (RSI)
  • BCS 56.40
  • RMD 41.83
  • Support Level
  • BCS $12.91
  • RMD $231.18
  • Resistance Level
  • BCS $13.40
  • RMD $255.16
  • Average True Range (ATR)
  • BCS 0.24
  • RMD 5.65
  • MACD
  • BCS 0.00
  • RMD -1.55
  • Stochastic Oscillator
  • BCS 69.51
  • RMD 15.26

About BCS Barclays PLC

Barclays is a universal bank headquartered in the United Kingdom. It operates via five principal segments; UK (retail), UK corporate bank, private bank and wealth management, investment bank, and us consumer bank. In its UK segment, the bank provides current accounts, mortgages, savings and investment management services, credit cards, and business banking services to retail clients and small and medium-size enterprises. The international segment includes a corporate bank offering banking solutions to large corporates, a bulge-bracket global investment bank, and a credit card and payments business.

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Share on Social Networks: